ARF5 and hepatocellular carcinoma: After further analysis, we found that the high expression of ARF5 was significantly negatively correlated with the survival time of HCC patients such as OS, DFI, PFI and DSS, indicating that ARF5 is a cancer biomarker with great potential research value.